These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25946031)

  • 1. Therapeutic Effectiveness of Screening for Multiple Endocrine Neoplasia Type 2A.
    Machens A; Dralle H
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2539-45. PubMed ID: 25946031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early, Prophylactic Thyroidectomy in Hereditary Medullary Thyroid Carcinoma: A 26-year Monoinstitutional Experience.
    Pelizzo MR; Torresan F; Boschin IM; Nacamulli D; Pennelli G; Barollo S; Rubello D; Mian C
    Am J Clin Oncol; 2015 Oct; 38(5):508-13. PubMed ID: 24064755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular epidemiology of multiple endocrine neoplasia 2: implications for RET screening in the new millenium.
    Machens A; Lorenz K; Sekulla C; Höppner W; Frank-Raue K; Raue F; Dralle H
    Eur J Endocrinol; 2013 Mar; 168(3):307-14. PubMed ID: 23211574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature].
    de Groot JW; Links TP; Rouwe CW; van der Wal JE; Hofstra RM; Plukker JT
    Ned Tijdschr Geneeskd; 2006 Feb; 150(6):311-8. PubMed ID: 16503023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship.
    Yip L; Cote GJ; Shapiro SE; Ayers GD; Herzog CE; Sellin RV; Sherman SI; Gagel RF; Lee JE; Evans DB
    Arch Surg; 2003 Apr; 138(4):409-16; discussion 416. PubMed ID: 12686527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B.
    O'Riordain DS; O'Brien T; Weaver AL; Gharib H; Hay ID; Grant CS; van Heerden JA
    Surgery; 1994 Dec; 116(6):1017-23. PubMed ID: 7985081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic screening of patients with medullary thyroid cancer in a referral center in Greece during the past two decades.
    Sarika HL; Papathoma A; Garofalaki M; Saltiki K; Pappa T; Pazaitou-Panayiotou K; Anastasiou E; Alevizaki M
    Eur J Endocrinol; 2015 Apr; 172(4):501-9. PubMed ID: 25624014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene].
    Fitze G; Saeger HD; Roesner D; Schackert HK
    Klin Padiatr; 2004; 216(5):270-6. PubMed ID: 15455293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Profile of the RET A883F Germline Mutation: An International Collaborative Study.
    Mathiesen JS; Habra MA; Bassett JHD; Choudhury SM; Balasubramanian SP; Howlett TA; Robinson BG; Gimenez-Roqueplo AP; Castinetti F; Vestergaard P; Frank-Raue K
    J Clin Endocrinol Metab; 2017 Jun; 102(6):2069-2074. PubMed ID: 28323957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mutations of ret-proto-oncogene in thyroid medullary carcinoma].
    Frank-Raue K; Höppner W; Buhr H; Herfarth C; Ziegler R; Raue F
    Dtsch Med Wochenschr; 1997 Feb; 122(6):143-9. PubMed ID: 9081799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
    Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of multiple endocrine neoplasia type 2A in children: therapeutic results of early thyroidectomy and prognostic value of codon analysis.
    Szinnai G; Meier C; Komminoth P; Zumsteg UW
    Pediatrics; 2003 Feb; 111(2):E132-9. PubMed ID: 12563086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center.
    Elisei R; Romei C; Cosci B; Agate L; Bottici V; Molinaro E; Sculli M; Miccoli P; Basolo F; Grasso L; Pacini F; Pinchera A
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4725-9. PubMed ID: 17895320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.
    Moore SW; Appfelstaedt J; Zaahl MG
    J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do the recent American Thyroid Association (ATA) Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A?
    Grubbs EG; Waguespack SG; Rich TA; Xing Y; Ying AK; Evans DB; Lee JE; Perrier ND
    Surgery; 2010 Dec; 148(6):1302-9; discussion 1309-10. PubMed ID: 21134565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEN 2A family--prophylactic thyroidectomy for asymptomatic siblings with positive 634 codon mutation.
    Agarwal S; Agarwal A; Chand G; Gupta SK; Jain M; Ramakant P
    J Assoc Physicians India; 2012 Feb; 60():127-9. PubMed ID: 22715565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peak incidence of pheochromocytoma and primary hyperparathyroidism in multiple endocrine neoplasia 2: need for age-adjusted biochemical screening.
    Machens A; Lorenz K; Dralle H
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E336-45. PubMed ID: 23284010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic thyroidectomy in pediatric carriers of multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma: mutation in C620 is associated with Hirschsprung's disease.
    Bütter A; Gagné J; Al-Jazaeri A; Emran MA; Deal C; St-Vil D
    J Pediatr Surg; 2007 Jan; 42(1):203-6. PubMed ID: 17208566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations.
    Rich TA; Feng L; Busaidy N; Cote GJ; Gagel RF; Hu M; Jimenez C; Lee JE; Perrier N; Sherman SI; Waguespack SG; Ying A; Grubbs E
    Thyroid; 2014 Jul; 24(7):1096-106. PubMed ID: 24617864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical spectrum of RET proto-oncogene mutations in codon 790.
    Bihan H; Murat A; Fysekidis M; Al-Salameh A; Schwartz C; Baudin E; Thieblot P; Borson-Chazot F; Guillausseau PJ; Cardot-Bauters C; Raingeard I; Requeda E; Sadoul JL; Reznik Y;
    Eur J Endocrinol; 2013 Sep; 169(3):271-6. PubMed ID: 23756355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.